SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-06-10 13:24
Tx date 2025-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Restricted Share Units
50 - Grant of options
+2,645 vol 		2,645
Filed 2025-06-10 13:23
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2025-06-10 13:21
Tx date 2025-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+17,012 vol 		126,029
Filed 2025-06-10 13:09
Tx date 2025-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$-91.44
-3 vol
$30.48 each 		5,141
Filed 2025-05-20 12:18
Tx date 2025-05-14 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		109,017
Filed 2025-05-20 12:00
Tx date 2025-05-14 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$64,660
+5,144 vol
$12.57 each 		5,144
Filed 2024-06-07 14:21
Tx date 2024-06-05 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$593,082
+15,542 vol
$38.16 each 		114,161
Filed 2024-06-05 10:26
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-141,011 vol 		0
Filed 2024-06-05 10:26
Tx date 2024-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
-81,000 vol 		0
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each 		2,000
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each 		4,000
Filed 2024-03-13 17:50
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each 		9,000
Filed 2024-03-13 17:49
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each 		14,000
Filed 2024-03-12 19:17
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each
Filed 2024-03-12 19:16
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each
Filed 2024-03-12 19:17
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-92,402.40
-2,000 vol
$46.20 each 		2,000
Filed 2024-03-12 19:16
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,512.50
-5,000 vol
$46.30 each 		4,000
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-231,250
-5,000 vol
$46.25 each 		9,000
Filed 2024-03-12 19:15
Tx date 2024-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-46,450
-1,000 vol
$46.45 each 		14,000
Filed 2023-06-14 17:39
Tx date 2023-06-14 		$FUSN
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+17,000 vol 		81,000
Filed 2023-06-05 13:26
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		98,619
Filed 2022-06-29 18:45
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		80,144
Filed 2022-06-22 22:03
Tx date 2022-06-14 		$FUSN
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+17,000 vol 		64,000
Filed 2022-05-25 11:42
Tx date 2022-05-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+15,000 vol 		15,000
Filed 2022-05-25 11:41
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-25 10:41
Tx date 2022-05-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-15,000 vol 		0
Filed 2021-06-07 16:50
Tx date 2021-06-04 		$FUSN
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+17,000 vol 		47,000
Filed 2021-06-03 21:50
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		62,144
Filed 2020-07-03 17:20
Tx date 2020-06-25 		$
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		30,000
Filed 2020-07-03 17:19
Tx date 2020-06-25 		$
Fusion Pharmaceuticals Inc. 		Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		141,011
Filed 2020-06-02 19:48
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		52,144
Filed 2019-09-19 15:56
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		42,144
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		27,144
Filed 2017-08-14
Tx date 2017-08-11 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$42,267
+15,000 vol
$2.82 each 		15,000
Filed 2017-08-14
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		12,144
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		8,644
Filed 2015-05-25
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+5,144 vol 		5,144
Filed 2015-05-25
Tx date 2015-05-21 		$XENE
Xenon Pharmaceuticals Inc. 		Gannon, Steven
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report